Radiopharmaceutical Manufacturing: A High-Stakes Race Against Time

From the executive boardrooms of pharma companies to academic research centers, one fact is becoming unmistakably clear: making radiopharmaceuticals is an inherently complex, high-stakes endeavor, and the industry is racing to manage the risks of these perishable therapies before the clock runs out The post Radiopharmaceutical Manufacturing: A High-Stakes Race Against Time appeared first on…

Read More

How Expanded Reimbursement for Coronary CTA (CCTA) Could Improve Cardiovascular Outcomes

With better access to tools like CCTA and diagnostic tools that leverage CCTA, clinicians can better support their patients in managing overall cardiovascular health, patients will benefit from less invasive care and enhanced quality of life, and health systems could ultimately see reduced costs and streamlined workflows.  The post How Expanded Reimbursement for Coronary CTA…

Read More